Pay in 4 interest-free payments of $5.29 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, et al
Glucagon-like peptide-1 receptor agonists, aka GLP-1 drugs, were originally approved and used for treatment of Type 2 diabetes, with the first product debuting in 2005
, -, , BDNF ( ) , IP4 BDNF
doi: 10.1016/J.ECLINM.2022.101624 194 AyoubkhaniDBerminghamCPouwelsKBGlickmanMNafilyanVZaccardiFet al
Based on the trials being conducted, retatrutide will likely be intended for: Primary target: Adults with obesity (BMI 30) or overweight (BMI 27) with at least one weight-related medical comorbidity (type 2 diabetes, hypertension, sleep apnea, osteoarthritis, etc.)
US$ 22.06
US$ 19.98
US$ 27.53
US$ 25.77
US$ 28.42
